BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24411620)

  • 1. Performance of a nomogram predicting disease-specific survival after an R0 resection for gastric cancer in patients receiving postoperative chemoradiation therapy.
    Dikken JL; Coit DG; Baser RE; Gönen M; Goodman KA; Brennan MF; Jansen EP; Boot H; van de Velde CJ; Cats A; Verheij M
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):624-9. PubMed ID: 24411620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the Memorial Sloan Kettering Cancer Center nomogram to predict disease-specific survival in a Chinese gastric cancer population receiving postoperative chemoradiotherapy after an R0 resection.
    Zhou ML; Wang L; Wang JZ; Yang W; Hu R; Li GC; Sheng WQ; Zhang Z
    Oncotarget; 2016 Oct; 7(40):64757-64765. PubMed ID: 27588465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.
    Chen D; Jiang B; Xing J; Liu M; Cui M; Liu Y; Wang Z; Chen L; Yang H; Zhang C; Yao Z; Zhang N; Ji J; Qu H; Su X
    PLoS One; 2013; 8(10):e76041. PubMed ID: 24146811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a gastric cancer nomogram using a cancer registry.
    Ashfaq A; Kidwell JT; McGhan LJ; Dueck AC; Pockaj BA; Gray RJ; Bagaria SP; Wasif N
    J Surg Oncol; 2015 Sep; 112(4):377-80. PubMed ID: 26271201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting individual survival after gastric cancer resection: validation of a U.S.-derived nomogram at a single high-volume center in Europe.
    Novotny AR; Schuhmacher C; Busch R; Kattan MW; Brennan MF; Siewert JR
    Ann Surg; 2006 Jan; 243(1):74-81. PubMed ID: 16371739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.
    Strong VE; Song KY; Park CH; Jacks LM; Gonen M; Shah M; Coit DG; Brennan MF
    Ann Surg; 2010 Apr; 251(4):640-6. PubMed ID: 20224369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer.
    Dikken JL; Baser RE; Gonen M; Kattan MW; Shah MA; Verheij M; van de Velde CJ; Brennan MF; Coit DG
    Ann Surg Oncol; 2013 May; 20(5):1623-30. PubMed ID: 23143591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP
    BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
    Kim SY; Yoon MJ; Park YI; Kim MJ; Nam BH; Park SR
    Gastric Cancer; 2018 May; 21(3):453-463. PubMed ID: 28828688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
    Stiekema J; Trip AK; Jansen EP; Boot H; Cats A; Ponz OB; Verheij M; van Sandick JW
    Ann Surg Oncol; 2014 Apr; 21(4):1107-14. PubMed ID: 24306660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
    Lee SJ; Sohn TS; Lee J; Park SH; Park JO; Lim DH; Park YS; Lim HY; Choi MG; Lee JH; Bae JM; Kim S; Kang WK
    Anticancer Res; 2014 Nov; 34(11):6585-91. PubMed ID: 25368262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.
    Kim TH; Park SR; Ryu KW; Kim YW; Bae JM; Lee JH; Choi IJ; Kim YJ; Kim DY
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e585-92. PubMed ID: 22975616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer.
    Hirabayashi S; Kosugi S; Isobe Y; Nashimoto A; Oda I; Hayashi K; Miyashiro I; Tsujitani S; Kodera Y; Seto Y; Furukawa H; Ono H; Tanabe S; Kaminishi M; Nunobe S; Fukagawa T; Matsuo R; Nagai T; Katai H; Wakai T; Akazawa K
    Ann Oncol; 2014 Jun; 25(6):1179-84. PubMed ID: 24669009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and External Validation of a Simplified Nomogram Predicting Individual Survival After R0 Resection for Gastric Cancer: An International, Multicenter Study.
    Zheng ZF; Lu J; Wang W; Desiderio J; Li P; Xie JW; Wang JB; Lin JX; Parisi A; Zhou ZW; Huang CM; Zheng CH
    Ann Surg Oncol; 2018 Aug; 25(8):2383-2390. PubMed ID: 29881929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma.
    Gold JS; Tang LH; Gönen M; Coit DG; Brennan MF; Allen PJ
    Ann Surg Oncol; 2007 Nov; 14(11):3159-67. PubMed ID: 17680313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does adjuvant chemoradiotherapy improve the prognosis of gastric cancer after an r1 resection? Results from a dutch cohort study.
    Stiekema J; Trip AK; Jansen EP; Aarts MJ; Boot H; Cats A; Ponz OB; Gradowska PL; Verheij M; van Sandick JW
    Ann Surg Oncol; 2015 Feb; 22(2):581-8. PubMed ID: 25164039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population.
    Liu M; Qu H; Bu Z; Chen D; Jiang B; Cui M; Xing J; Yang H; Wang Z; Di J; Chen L; Zhang C; Yao Z; Zhang N; Tan F; Gu J; Li Z; Su X
    Ann Surg Oncol; 2015 Nov; 22(12):3881-7. PubMed ID: 25963477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ
    BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.